<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(5)</volume><submitter>Yu Z</submitter><pubmed_abstract>Direct data-independent acquisition (DIA) in liquid chromatography-tandem mass spectrometry (LC-MS/MS) has developed into a powerful methodology for proteomics. Herein, we directly compare the performance of two widely used DIA computational platformsSpectronaut and DIA-NNusing paired tumor and peritumor tissue biopsies from human lung carcinoma (LUAD) patients, samples that one would encounter in a clinical research lab in a hospital setting. The evaluations include the following: (1) protein identification depth, (2) quantitative consistency, and (3) differential expression on the same set of LC-MS/MS runs, using nominally identical computational parameters and settings. Both Spectronaut and DIA-NN identified ∼>7600 proteins in the LUAD samples, with 7180 proteins common to both platfo</pubmed_abstract><journal>ACS omega</journal><pagination>8080-8093</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12903166</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Spectronaut and DIA-NN: A Comparison of their Performance in the Analysis of Lung Adenocarcinoma Biopsies.</pubmed_title><pmcid>PMC12903166</pmcid><pubmed_authors>Zhang W</pubmed_authors><pubmed_authors>Chu IK</pubmed_authors><pubmed_authors>Du A</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Siu KWM</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Ma X</pubmed_authors><pubmed_authors>Yu Z</pubmed_authors><pubmed_authors>Xu X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Spectronaut and DIA-NN: A Comparison of their Performance in the Analysis of Lung Adenocarcinoma Biopsies.</name><description>Direct data-independent acquisition (DIA) in liquid chromatography-tandem mass spectrometry (LC-MS/MS) has developed into a powerful methodology for proteomics. Herein, we directly compare the performance of two widely used DIA computational platformsSpectronaut and DIA-NNusing paired tumor and peritumor tissue biopsies from human lung carcinoma (LUAD) patients, samples that one would encounter in a clinical research lab in a hospital setting. The evaluations include the following: (1) protein identification depth, (2) quantitative consistency, and (3) differential expression on the same set of LC-MS/MS runs, using nominally identical computational parameters and settings. Both Spectronaut and DIA-NN identified ∼>7600 proteins in the LUAD samples, with 7180 proteins common to both platfo</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-15T16:40:56.674Z</modification><creation>2026-07-07T03:08:22.861Z</creation></dates><accession>S-EPMC12903166</accession><cross_references><pubmed>41696233</pubmed><doi>10.1021/acsomega.5c10421</doi></cross_references></HashMap>